Francesco Negro
Effect of Direct Acting Antiviral Drugs on the Occurrence and Recurrence of Intra- and Extra-Hepatic Malignancies in Patients with Chronic Hepatitis C Virus Infection.
Radu P, Becchetti C, Schropp J, Schmid P, Künzler-Heule P, Mertens J, Moradpour D, Mullhaupt B, Semela D, Negro F, Heim M, Clerc O, Roelens M, Keiser O, Berzigotti A, Swiss Hepatitis C Cohort Study. Effect of Direct Acting Antiviral Drugs on the Occurrence and Recurrence of Intra- and Extra-Hepatic Malignancies in Patients with Chronic Hepatitis C Virus Infection. Cancers (Basel) 2024; 16
Jul 18, 2024Effect of Direct Acting Antiviral Drugs on the Occurrence and Recurrence of Intra- and Extra-Hepatic Malignancies in Patients with Chronic Hepatitis C Virus Infection.
Jul 18, 2024Cancers (Basel) 2024; 16
Radu Pompilia, Becchetti Chiara, Schropp Jonas, Schmid Patrick, Künzler-Heule Patrizia, Mertens Joachim C, Moradpour Darius, Mullhaupt Beat, Semela David, Negro Francesco, Heim Markus H, Clerc Olivier F, Roelens Maroussia, Keiser Olivia, Berzigotti Annalisa, Swiss Hepatitis C Cohort Study
Real-life experience of chronic hepatitis C treatment in Switzerland: a retrospective analysis.
Moschouri E, Salemme G, Baserga A, Cerny A, Deibel A, Muellhaupt B, Meier M, Bernsmeier C, Ongaro M, Negro F, Grosjean M, Clerc O, Künzler-Heule P, Semela D, Hobi G, Stickel F, Mathieu A, Mdawar-Bailly E, Faouzi M, Moradpour D, Fraga M. Real-life experience of chronic hepatitis C treatment in Switzerland: a retrospective analysis. Swiss Med Wkly 2024; 154:3698.
Jun 24, 2024Real-life experience of chronic hepatitis C treatment in Switzerland: a retrospective analysis.
Jun 24, 2024Swiss Med Wkly 2024; 154:3698
Moschouri Eleni, Salemme Gloria, Baserga Adriana, Cerny Andreas, Deibel Ansgar, Muellhaupt Beat, Meier Marie-Anne, Bernsmeier Christine, Ongaro Marie, Negro Francesco, Grosjean Marielle, Clerc Olivier F, Künzler-Heule Patrizia, Semela David, Hobi Gabriel, Stickel Felix, Mathieu Adeline, Mdawar-Bailly Elise, Faouzi Mohamed, Moradpour Darius, Fraga Montserrat
The current and future burden of hepatitis B in Switzerland: a modelling study.
Negro F, Muellhaupt B, Semela D, Blach S, Bruggmann P, De Gottardi A, Dufour J, Fraga M, Galante A, Razavi H, Vieira Barbosa J, Razavi-Shearer D. The current and future burden of hepatitis B in Switzerland: a modelling study. Swiss Med Wkly 2023; 153:40086.
Jun 5, 2023The current and future burden of hepatitis B in Switzerland: a modelling study.
Jun 5, 2023Swiss Med Wkly 2023; 153:40086
Negro Francesco, Muellhaupt Beat, Semela David, Blach Sarah, Bruggmann Philipp, De Gottardi Andrea, Dufour Jean-François, Fraga Montserrat, Galante Antonio, Razavi Homie, Vieira Barbosa Joana, Razavi-Shearer Devin
HCV disease burden and population segments in Switzerland
Bihl F, Semmo N, Semela D, Scheidegger C, Razavi H, Negro F, Mullhaupt B, Lavanchy D, Dufour J, Castro Batänjer E, Bruggmann P, Blach S. HCV disease burden and population segments in Switzerland. Liver Int 2021
Nov 27, 2021HCV disease burden and population segments in Switzerland
Nov 27, 2021Liver Int 2021
Bihl Florian, Semmo Nasser, Semela David, Scheidegger Claude, Razavi Homie, Negro Francesco, Mullhaupt Beat, Lavanchy Daniel, Dufour Jean-François, Castro Batänjer Erika, Bruggmann Philip, Blach Sarah
Empfehlungen für die Nachsorge von Patientinnen/Patienten mit ausgeheilter Hepatitis C
Bobzin C, Semmo N, Semela D, Scheidegger C, Rauch A, Negro F, Moradpour D, Mäschli B, Lavanchy D, Künzler-Heule P, Keiser O, Fraga Christinet M, Cerny A, Bruggmann P, Bösiger C, Thurnheer M. Empfehlungen für die Nachsorge von Patientinnen/Patienten mit ausgeheilter Hepatitis C. Swiss Medical Forum 2021; 21:184-186.
Mar 17, 2021Empfehlungen für die Nachsorge von Patientinnen/Patienten mit ausgeheilter Hepatitis C
Mar 17, 2021Swiss Medical Forum 2021; 21:184-186
Bobzin Carina, Semmo Nasser, Semela David, Scheidegger Claude, Rauch Andri, Negro Francesco, Moradpour Darius, Mäschli Bettina, Lavanchy D, Künzler-Heule Patrizia, Keiser Olivia, Fraga Christinet Montserrat, Cerny Andreas, Bruggmann Philip, Bösiger Christophe, Thurnheer Maria Christine
Real-world effectiveness and safety of glecaprevir/pibrentasvir therapy in patients with chronic hepatitis C virus infection in Switzerland
Mullhaupt B, Semela D, Ruckstuhl L, Magenta L, Clerc O, Torgler R, Negro F, Semmo N. Real-world effectiveness and safety of glecaprevir/pibrentasvir therapy in patients with chronic hepatitis C virus infection in Switzerland. Swiss Med Wkly 2021; 151:w20399.
Jan 19, 2021Real-world effectiveness and safety of glecaprevir/pibrentasvir therapy in patients with chronic hepatitis C virus infection in Switzerland
Jan 19, 2021Swiss Med Wkly 2021; 151:w20399
Mullhaupt Beat, Semela David, Ruckstuhl Lisa, Magenta Lorenzo, Clerc Olivier, Torgler Ralph, Negro Francesco, Semmo Nasser
All-Cause Mortality and Causes of Death in the Swiss Hepatitis C Cohort Study (SCCS)
Roelens M, Keiser O, Negro F, Junker C, Semela D, Clerc O, Mullhaupt B, Schmid P, Semmo N, Cerny A, Moradpour D, Bertisch B, Swiss Hepatitis C Cohort Study. All-Cause Mortality and Causes of Death in the Swiss Hepatitis C Cohort Study (SCCS). Open Forum Infect Dis 2020; 7:ofaa308.
Jul 25, 2020All-Cause Mortality and Causes of Death in the Swiss Hepatitis C Cohort Study (SCCS)
Jul 25, 2020Open Forum Infect Dis 2020; 7:ofaa308
Roelens Maroussia, Keiser Olivia, Negro Francesco, Junker Christoph, Semela David, Clerc Olivier, Mullhaupt Beat, Schmid Patrick, Semmo Nasser, Cerny Andreas, Moradpour Darius, Bertisch Barbara, Swiss Hepatitis C Cohort Study
Nonalcoholic fatty liver disease burden - Switzerland 2018-2030
Goossens N, Semela D, Razavi H, Negro F, Muellhaupt B, Moriggia A, Mertens J, Jornayvaz F, Dufour J, Cerny A, Bellentani S, Estes C. Nonalcoholic fatty liver disease burden - Switzerland 2018-2030. Swiss Med Wkly 2019; 149:w20152.
Dec 17, 2019Nonalcoholic fatty liver disease burden - Switzerland 2018-2030
Dec 17, 2019Swiss Med Wkly 2019; 149:w20152
Goossens Nicolas, Semela David, Razavi Homie, Negro Francesco, Muellhaupt Beat, Moriggia Alberto, Mertens Joachim, Jornayvaz François R, Dufour Jean-François, Cerny Andreas, Bellentani Stefano, Estes Chris
Impact of geographic origin on access to therapy and therapy outcomes in the Swiss Hepatitis C Cohort Study
Brezzi M, Keiser O, Negro F, Semela D, Mullhaupt B, Semmo N, Terziroli Beretta-Piccoli B, Moradpour D, Roelens M, Bertisch B, Swiss Hepatitis C Cohort Study. Impact of geographic origin on access to therapy and therapy outcomes in the Swiss Hepatitis C Cohort Study. PloS one 2019; 14:e0218706.
Jun 24, 2019Impact of geographic origin on access to therapy and therapy outcomes in the Swiss Hepatitis C Cohort Study
Jun 24, 2019PloS one 2019; 14:e0218706
Brezzi Matteo, Keiser Olivia, Negro Francesco, Semela David, Mullhaupt Beat, Semmo Nasser, Terziroli Beretta-Piccoli Benedetta, Moradpour Darius, Roelens Maroussia, Bertisch Barbara, Swiss Hepatitis C Cohort Study
Very low hepatitis C viral loads in treatment-naïve persons: do they compromise hepatitis C virus antigen testing?
Bertisch B, Keiser O, Moradpour D, Zehnder C, Marinucci F, Roelens M, Moriggia A, Clerc O, Giudici F, Schmid P, Künzler-Heule P, Ottiger C, Mullhaupt B, Negro F, Brezzi M, Swiss Hepatitis C Cohort Study. Very low hepatitis C viral loads in treatment-naïve persons: do they compromise hepatitis C virus antigen testing?. Clin Infect Dis 2019
Apr 3, 2019Very low hepatitis C viral loads in treatment-naïve persons: do they compromise hepatitis C virus antigen testing?
Apr 3, 2019Clin Infect Dis 2019
Bertisch Barbara, Keiser Olivia, Moradpour Darius, Zehnder Cinzia, Marinucci Francesco, Roelens Maroussia, Moriggia Alberto, Clerc Olivier, Giudici Fabio, Schmid Patrick, Künzler-Heule Patrizia, Ottiger Cornelia, Mullhaupt Beat, Negro Francesco, Brezzi Matteo, Swiss Hepatitis C Cohort Study
Microelimination of chronic hepatitis C in Switzerland: modelling the Swiss Hepatitis Strategy goals in eastern, western and northern regions
Rusch U, Robbins S, Razavi H, Vernazza P, Blach S, Bruggmann P, Mullhaupt B, Negro F, Semela D. Microelimination of chronic hepatitis C in Switzerland: modelling the Swiss Hepatitis Strategy goals in eastern, western and northern regions. Swiss Med Wkly 2019; 149:w14694.
Jan 23, 2019Microelimination of chronic hepatitis C in Switzerland: modelling the Swiss Hepatitis Strategy goals in eastern, western and northern regions
Jan 23, 2019Swiss Med Wkly 2019; 149:w14694
Rusch Urs, Robbins Sarah, Razavi Homie, Vernazza Pietro, Blach Sarah, Bruggmann Philip, Mullhaupt Beat, Negro Francesco, Semela David
Progress toward implementing the Swiss Hepatitis Strategy: Is HCV elimination possible by 2030?
Mullhaupt B, Bruggmann P, Bihl F, Blach S, Lavanchy D, Razavi H, Robbins Scott S, Semela D, Negro F. Progress toward implementing the Swiss Hepatitis Strategy: Is HCV elimination possible by 2030?. PloS one 2018; 13:e0209374.
Dec 31, 2018Progress toward implementing the Swiss Hepatitis Strategy: Is HCV elimination possible by 2030?
Dec 31, 2018PloS one 2018; 13:e0209374
Mullhaupt Beat, Bruggmann Philip, Bihl Florian, Blach Sarah, Lavanchy Daniel, Razavi Homie, Robbins Scott Sarah, Semela David, Negro Francesco
A systematic review and meta-analysis of HCV clearance
Gauthiez E, Moradpour D, Mullhaupt B, Negro F, Semela D, Semmo N, Villard J, Bibert S, Bochud P, Malinverni R, Heim M, Habfast-Robertson I, Rüeger S, Kutalik Z, Aubert V, Berg T, Cerny A, Gorgievski M, George J, Swiss Hepatitis C Cohort Study. A systematic review and meta-analysis of HCV clearance. Liver Int 2017; 37:1431-1445.
Mar 30, 2017A systematic review and meta-analysis of HCV clearance
Mar 30, 2017Liver Int 2017; 37:1431-1445
Gauthiez Emeline, Moradpour Darius, Mullhaupt Beat, Negro Francesco, Semela David, Semmo Nasser, Villard Jean, Bibert Stéphanie, Bochud Pierre-Yves, Malinverni Raffaele, Heim Markus H, Habfast-Robertson Ines, Rüeger Sina, Kutalik Zoltán, Aubert Vincent, Berg Thomas, Cerny Andreas, Gorgievski Meri, George Jacob, Swiss Hepatitis C Cohort Study
Birth cohort distribution and screening for viraemic hepatitis C virus infections in Switzerland
Bruggmann P, Negro F, Bihl F, Blach S, Lavanchy D, Mullhaupt B, Razavi H, Semela D. Birth cohort distribution and screening for viraemic hepatitis C virus infections in Switzerland. Swiss Med Wkly 2015; 145:w14221.
Dec 4, 2015Birth cohort distribution and screening for viraemic hepatitis C virus infections in Switzerland
Dec 4, 2015Swiss Med Wkly 2015; 145:w14221
Bruggmann Philip, Negro Francesco, Bihl Florian, Blach Sarah, Lavanchy Daniel, Mullhaupt Beat, Razavi Homie, Semela David
Corrigendum: reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes
Terczyńska-Dyla E, Moradpour D, Mullhaupt B, Negro F, Santoro R, Semela D, Semmo N, Swiss Hepatitis C Cohort Study Group, Heim M, Bochud P, Mangia A, Malinverni R, Bibert S, Duong F, Krol I, Jørgensen S, Collinet E, Kutalik Z, Aubert V, Cerny A, Kaiser L, Hartmann R. Corrigendum: reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes. Nat Commun 2015; 6:7280.
Jun 29, 2015Corrigendum: reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes
Jun 29, 2015Nat Commun 2015; 6:7280
Terczyńska-Dyla Ewa, Moradpour Darius, Mullhaupt Beat, Negro Francesco, Santoro Rosanna, Semela David, Semmo Nasser, Swiss Hepatitis C Cohort Study Group, Heim Markus H, Bochud Pierre-Yves, Mangia Alessandra, Malinverni Raffaele, Bibert Stéphanie, Duong Francois H T, Krol Ilona, Jørgensen Sanne, Collinet Emilie, Kutalik Zoltán, Aubert Vincent, Cerny Andreas, Kaiser Laurent, Hartmann Rune
Modeling the Health and Economic Burden of Hepatitis C Virus in Switzerland
Mullhaupt B, Bruggmann P, Bihl F, Blach S, Lavanchy D, Razavi H, Semela D, Negro F. Modeling the Health and Economic Burden of Hepatitis C Virus in Switzerland. PloS one 2015; 10:e0125214.
Jun 24, 2015Modeling the Health and Economic Burden of Hepatitis C Virus in Switzerland
Jun 24, 2015PloS one 2015; 10:e0125214
Mullhaupt Beat, Bruggmann Philip, Bihl Florian, Blach Sarah, Lavanchy Daniel, Razavi Homie, Semela David, Negro Francesco
Reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes
Terczyńska-Dyla E, Moradpour D, Mullhaupt B, Negro F, Santoro R, Semela D, Semmo N, Swiss Hepatitis C Cohort Study Group, Heim M, Bochud P, Mangia A, Malinverni R, Bibert S, Duong F, Krol I, Jørgensen S, Collinet E, Kutalik Z, Aubert V, Cerny A, Kaiser L, Hartmann R. Reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes. Nat Commun 2014; 5:5699.
Dec 23, 2014Reduced IFNλ4 activity is associated with improved HCV clearance and reduced expression of interferon-stimulated genes
Dec 23, 2014Nat Commun 2014; 5:5699
Terczyńska-Dyla Ewa, Moradpour Darius, Mullhaupt Beat, Negro Francesco, Santoro Rosanna, Semela David, Semmo Nasser, Swiss Hepatitis C Cohort Study Group, Heim Markus H, Bochud Pierre-Yves, Mangia Alessandra, Malinverni Raffaele, Bibert Stéphanie, Duong Francois H T, Krol Ilona, Jørgensen Sanne, Collinet Emilie, Kutalik Zoltán, Aubert Vincent, Cerny Andreas, Kaiser Laurent, Hartmann Rune
Genetic analyses reveal a role for vitamin D insufficiency in HCV-associated hepatocellular carcinoma development
Lange C, Negro F, Semela D, Kutalik Z, Müller T, Spengler U, Berg T, Chayama K, Moradpour D, Bochud P, Hiroshima Liver Study Group, Mullhaupt B, Malinverni R, Heim M, Miki D, Ochi H, Nischalke H, Bojunga J, Bibert S, Morikawa K, Gouttenoire J, Cerny A, Dufour J, Gorgievski-Hrisoho M, Swiss Hepatitis C Cohort Study Group. Genetic analyses reveal a role for vitamin D insufficiency in HCV-associated hepatocellular carcinoma development. PloS one 2013; 8:e64053.
May 29, 2013Genetic analyses reveal a role for vitamin D insufficiency in HCV-associated hepatocellular carcinoma development
May 29, 2013PloS one 2013; 8:e64053
Lange Christian M, Negro Francesco, Semela David, Kutalik Zoltán, Müller Tobias, Spengler Ulrich, Berg Thomas, Chayama Kazuaki, Moradpour Darius, Bochud Pierre-Yves, Hiroshima Liver Study Group, Mullhaupt Beat, Malinverni Raffaele, Heim Markus H, Miki Daiki, Ochi Hidenori, Nischalke Hans-Dieter, Bojunga Jörg, Bibert Stéphanie, Morikawa Kenichi, Gouttenoire Jérôme, Cerny Andreas, Dufour Jean-François, Gorgievski-Hrisoho Meri, Swiss Hepatitis C Cohort Study Group
Comparative genetic analyses point to HCP5 as susceptibility locus for HCV-associated hepatocellular carcinoma
Lange C, Bochud P, Kutalik Z, Moradpour D, Semela D, Negro F, Mullhaupt B, Malinverni R, Kaiser L, Heim M, Cerny A, Cellerai C, Dufour J, Bibert S, Swiss Hepatitis C Cohort Study Group. Comparative genetic analyses point to HCP5 as susceptibility locus for HCV-associated hepatocellular carcinoma. J Hepatol 2013; 59:504-9.
May 9, 2013Comparative genetic analyses point to HCP5 as susceptibility locus for HCV-associated hepatocellular carcinoma
May 9, 2013J Hepatol 2013; 59:504-9
Lange Christian M, Bochud Pierre-Yves, Kutalik Zoltán, Moradpour Darius, Semela David, Negro Francesco, Mullhaupt Beat, Malinverni Raffaele, Kaiser Laurent, Heim Markus H, Cerny Andreas, Cellerai Cristina, Dufour Jean-François, Bibert Stéphanie, Swiss Hepatitis C Cohort Study Group
Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinoma
Kuske L, Dufour J, Cerny A, Malinverni R, Heim M, Malé P, Moradpour D, Semela D, Negro F, Mullhaupt B, Mensen A, Swiss Hepatitis C Cohort Study. Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinoma. Swiss Med Wkly 2012; 142:w13651.
Aug 6, 2012Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinoma
Aug 6, 2012Swiss Med Wkly 2012; 142:w13651
Kuske Lorenz, Dufour Jean-François, Cerny Andreas, Malinverni Raffaele, Heim Markus H, Malé Pierre Jean, Moradpour Darius, Semela David, Negro Francesco, Mullhaupt Beat, Mensen Armand, Swiss Hepatitis C Cohort Study